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Several years ago, I attended a
Keystone meeting on the mechanism
of transcriptional activation. One of
the speakers concluded his talk by
listing a number of outstanding
questions concerning the structure of
a particular type of domain shared by
many activator proteins. At a poster
session later that day I told this
speaker that one of my graduate
students had, in fact, already
answered one of the questions posed
at the end of his lecture and that we
had published the result. The speaker
was quite surprised that he had
missed this paper and asked me for
the reference. When I told him, he
regarded me with a somewhat
incredulous expression and inquired
why we had published such an
interesting result in such an obscure
journal. The article had appeared as a
Communication to the Editor in the
Journal of the American Chemical Society.
That a leading molecular biologist
would place the flagship journal of
the chemical community somewhere
below Better Homes & Gardens on
his ‘to read’ list may strike chemists
as remarkable. But, on the other
hand, how many synthetic chemists
sift through Genes & Development or
Molecular & Cellular Biology? It is
precisely to address this problem that
Chemistry & Biology was launched. By
publishing informative reviews,
thought-provoking crosstalk features
and, of course, cutting-edge original
research papers on science at the
chemistry–biology interface,
Chemistry & Biology was designed to
be a venue where chemists and
biologists could trade ideas, make
each other aware of important
research opportunities and generally
interact in an intellectually satisfying
way. By several measures, the journal
is a big success. It has an impact
rating comparable or superior to
many more mature publications and
seems to be held in high regard by
the practitioners of chemical biology,
as evidenced by the many high-
quality publications that appear
regularly. So, as a new year (century,
millenium) dawns, what are the
major issues that the journal and the
chemical biology community in
general must address? I would like to
suggest here that a major challenge
will be to engage a much greater
fraction of the general molecular and
cellular biology community in
Chemistry & Biology in particular and
chemical biology in general. 
My own informal and unscientific
impression, based on day-to-day
interactions with biologists, is that
Chemistry & Biology has a much lower
visibility in the mainstream
molecular/cell biology community
than it does amongst organic
chemists. Few of these researchers
think about publishing in Chemistry &
Biology and most don’t read it. There
are several reasons for this. One is the
sheer size of the molecular biology
community and the remarkable pace
with which the field moves. Long
before Chemistry & Biology debuted,
there were already a daunting number
of journals that had to be at least
scanned in order to keep up with
one’s particular area of interest. It is
difficult for any new journal in the
biological area to rise above this dense
forest of established publications.
This information overload is
compounded by the fact that (to be
really honest) most biologists don’t
understand organic chemistry. With a
few shining exceptions, the area of
chemical biology is dominated by
individuals who have been trained as
chemists and then picked up some
level of expertise in molecular
biology/biochemistry. So it is difficult
for a mainstream molecular or cell
biologist to be interested in many of
the more mechanistic and synthetic
articles that appear in the journal.
That’s OK; one can’t know
everything and most of us don't read
all of the articles in any single journal
anyway. But my strong impression is
that most biologists, if they know
about the journal, think that
everything in Chemistry & Biology is of
this ilk. There is the mistaken
perception is that if you don’t use
ChemDraw frequently in the
preparation of a manuscript, then it
probably isn’t suitable for Chemistry &
Biology. For this reason, the journal is
off the radar screen of many of these
individuals. 
Although it is tempting to say “so
what?” and just assume that no
single journal can appeal to
everyone, here is the rub (actually
one of several rubs). Many chemical
biologists are focused on the
development of new techniques,
grounded in chemical thinking, that
allow biological problems to be
probed in ways not possible with
standard biological methods.
Although the details of this type of
research and the thinking that goes
into the design of these methods are
best appreciated by researchers with
a strong chemical background, the
final product will be mostly useful to
biologists who may not appreciate
how something works, but are very
happy to use an effective and
innovative technique nonetheless. A
real danger to the journal is that
these chemical biologists will take
their best papers elsewhere if they
conclude that only a small fraction of
the potential users will see it in
Chemistry & Biology. I use technology
development as an example because
it is near and dear to my own heart.
But one could make a similar
argument for the identification of a
natural product receptor that opens
up new insights into a particular
biological pathway or many other
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types of research in which chemical
biologists engage.
So, what’s the answer? Certainly this
problem will self-correct over time as
more and more biologists realize
what chemistry can do for them and
as a new generation of scientists are
trained in programs where biology
and chemistry are more freely mixed.
But, in the short term, how can we
jump start the process of getting
more traditional cell and molecular
biologists interested in Chemistry &
Biology and, by extension, chemical
approaches to biological questions?
My first thought, free Dallas
Cowboys season tickets with every
new subscription, probably won’t fly
with the publishers, but there are
other mechanisms. One is to
convince more biologists to publish
in Chemistry & Biology (everyone
wants to read their own papers). As a
new Associate Editor, I hope to
foster this by inviting prominent
molecular biologists to write
Crosstalk articles as one way to begin
to better engage them in a dialogue
with the chemical biology
community. But more importantly,
we need to convince more of the
biological community to consider
publishing original research in
Chemistry & Biology when appropriate.
This will require some beating of the
bushes and, in the process, correcting
some of the misconceptions about
suitable content mentioned above. 
Although articles that feature
bioactive small molecules, synthesis
and so on will, and should, continue
to be a staple of the Chemistry &
Biology portfolio, there is ample room
for more traditional molecular
biological work if it of obvious
interest somewhere down the line to
chemists. The discovery of any new
protein, gene or protein–protein
interaction that might constitute a
potential drug target is an obvious
example of this type of publication.
Another would be a mutagenesis
study that revealed how, in principle,
a biological pathway could be
manipulated if one had a molecule
that could mimic the effect of a
particular mutation. 
I’d like to ask everyone with a stake
in the health of Chemistry & Biology as
the voice of the chemical biology
community to aid in this process.
When we go to biology meetings,
give seminars in biology departments
and at biotechnology companies, or
have lunch with our biological
colleagues at home, we should make
every effort to encourage their
participation in the journal. I would
hope that in the future when I tell a
prominent molecular biologist about
a result published in Chemistry &
Biology the response will be: “I
enjoyed reading that article!”
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